ArthroCare takes spine cancer device to US
This article was originally published in Clinica
Executive Summary
ArthroCare has received US FDA approval to market its Cavity SpineWand, for removing cancer lesions within the vertebrae. The Austin, Texas firm claims that the device can reduce pain caused by vertebral compression fractures, which often occur as a result of these spine tumours.